Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients (DOPPIO): Protocol for a Prospective Multicenter Study

Autor: Sibylle Mellinghoff, Gero von Gersdorff, Caroline Bruns, Kerstin Albus, Vassiliki Dimitriou, Angela Steinbach, Mathias Schaller, Jörg Janne Vehreschild, Oliver A Cornely, Blasius Janusch Liss

Publikováno v: JMIR Research Protocols, Vol 12, p e45712 (2023)

BackgroundPneumonia is a leading cause of death in patients with end-stage chronic kidney disease treated with dialysis. Current vaccination schedules recommend pneumococcal vaccination. However, this schedule disregards findings of rapid titer decli

Externí odkaz: https://doaj.org/article/6a87fbe104cf4e5b97a58eac9ded20a5

Use of intravenous iron and risk of anaphylaxis

Autor: Nicholas Moore, Patrick Blin, Jochen Dress, Antje Timmer, Jacques Benichou, Jonas Reinold, Ron M.C. Herings, Edeltraut Garbe, Ingvild Odsbu, Susana Perez-Gutthann, Nuria Saigi-Morgui, Gunnar Toft, Vera Ehrenstein, Cécile Droz-Perroteau, Andreas J. Bircher, D. S. Rampton, Michael Forstner, Carla Franzoni, Elisabeth Smits, Joan Fortuny, Régis Lassalle, Katherine Rascher, Gero von Gersdorff, Mathias Schaller, Kenneth J. Rothman, Jetty A. Overbeek, Tania Schink, Marie Linder, Bianca Kollhorst, Lawrence Rasouliyan, Lia Gutierrez

Publikováno v: Pharmacoepidemiology and Drug Safety
Pharmacoepidemiology and Drug Safety, Wiley, 2021, ⟨10.1002/pds.5319⟩
Pharmacoepidemiology and Drug Safety, 30(10), 1447-1457. John Wiley and Sons Ltd
Intravenous Iron Consortium 2021, ' Use of intravenous iron and risk of anaphylaxis : A multinational observational post-authorisation safety study in Europe ', Pharmacoepidemiology and Drug Safety, vol. 30, no. 10, pp. 1447-1457 . https://doi.org/10.1002/pds.5319

International audience; PURPOSE: This post-authorisation safety study estimated the risk of anaphylaxis in patients receiving intravenous (IV) iron in Europe, with interest in iron dextran and iron non-dextrans. Studies conducted in the United States

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e06c312f47a90c0a8bc0e2ccf6427694
https://doi.org/10.1002/pds.5319

MO930BURDEN OF DISEASE IN INCIDENT DIALYSIS PATIENTS WAIT LISTED FOR KIDNEY TRANSPLANTATION 2008 – 2016 IN GERMANY

Autor: Martin Wagner, Katherine Rascher, Gero von Gersdorff, Heyke Cramer, Mathias Schaller, Dieter Bach, Wolfgang Arns

Publikováno v: Nephrology Dialysis Transplantation. 36

Background and Aims Only a subset of all patients on dialysis is eligible for kidney transplantation (KTx) due to the large variation of mortality risk. It has been shown that the burden of disease is increasing over the last years in patients at dia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e2ffd4efae300e30982a5fe4e76e30ab
https://doi.org/10.1093/ndt/gfab110.009

High-pressure low-temperature phase transitions and structural development in quasi-two-dimensional transition metal oxychlorides

Autor: Achim Mathias Schaller, Maxim Bykov, Elena Bykova, Konstantin Glazyrin, Sander van Smaalen

Publikováno v: Acta Crystallographica Section A Foundations and Advances. 77:C537-C537

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ffb42a0e40d7d5bc81aee3b37fa8b82d
https://doi.org/10.1107/s0108767321091522

The Capital Buffer Calibration for Other Systemically Important Institutions – Is There Too Much Country Heterogeneity?

Autor: Mathias Schaller, Michael Sigmund

Publikováno v: SSRN Electronic Journal.

In this article, we discuss how the too-big-to-fail dilemma for large financial institution is addressed in the regulatory framework and how (differently) regulators in the EU apply it. The European Banking Authority (EBA) has devised a buffer guidel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d40bbe9ae7a9035b897280282b3d7cc7
https://doi.org/10.2139/ssrn.3216117